📅 19th - 20th June 2025 📍 Heathrow, London
Amgen Ltd.
Our robust pipeline and portfolio target some of the world’s most challenging diseases, including cancer, cardiovascular conditions, osteoporosis, inflammatory and rare diseases. We leverage advanced tools such as AI and generative biology to develop precision medicines that go beyond today’s standards of care.
Amgen’s therapies have reached millions of patients in nearly 100 countries, driven by a mission to help people live longer, healthier lives. Our medicines are produced through highly complex biological processes, and we are known for the reliability and quality of our global supply chain—delivering for every patient, every time.
As one of 30 companies in the Dow Jones Industrial Average® and part of the Nasdaq-100 Index®, Amgen operates with a strong sense of responsibility. We are committed not only to advancing science but also to making a broader positive impact—championing sustainability, ethics, and social responsibility in everything we do.